These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 38337030)

  • 1. New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief.
    Shahraki T; Baradaran-Rafii A; Ayyala R; Arabi A; Jarstad J; Memar F
    Int Ophthalmol; 2024 Feb; 44(1):49. PubMed ID: 38337030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing excessive evaporation: an unmet need in dry eye disease.
    Karpecki PM; Nichols KK; Sheppard JD
    Am J Manag Care; 2023 Oct; 29(13 Suppl):S239-S247. PubMed ID: 37844320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape.
    Sheppard JD; Nichols KK
    Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
    Baudouin C; Aragona P; Messmer EM; Tomlinson A; Calonge M; Boboridis KG; Akova YA; Geerling G; Labetoulle M; Rolando M
    Ocul Surf; 2013 Oct; 11(4):246-58. PubMed ID: 24112228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple technique of meibography for morphological and functional evaluation of meibomian glands in dry eye conditions.
    Mounika V; Kamath SJ; Tejaswi P; Kamath AR; Rodrigues GR; Mendonca TM
    Indian J Ophthalmol; 2023 Apr; 71(4):1420-1425. PubMed ID: 37026275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaporative dry eye disease due to meibomian gland dysfunction: Preferred practice pattern guidelines for diagnosis and treatment.
    Narang P; Donthineni PR; D'Souza S; Basu S
    Indian J Ophthalmol; 2023 Apr; 71(4):1348-1356. PubMed ID: 37026266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Meibomian Glands - An Overview.
    Dietrich J; Garreis F; Paulsen F
    Ocul Immunol Inflamm; 2021 May; 29(4):803-810. PubMed ID: 33945389
    [No Abstract]   [Full Text] [Related]  

  • 13. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
    Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease.
    Zhuang-Yan A; Syed YY
    Drugs; 2024 Apr; 84(4):441-448. PubMed ID: 38554243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study.
    Fukuoka S; Arita R
    Sci Rep; 2019 Jun; 9(1):9091. PubMed ID: 31235821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of dry eye disease and novel therapeutic targets.
    Messmer EM
    Exp Eye Res; 2022 Apr; 217():108944. PubMed ID: 35077753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative of meibomian gland morphology in patients with evaporative dry eye disease versus non-dry eye disease.
    Crespo-Treviño RR; Salinas-Sánchez AK; Amparo F; Garza-Leon M
    Sci Rep; 2021 Oct; 11(1):20729. PubMed ID: 34671059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
    Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
    Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.